Tenderwize
Wróć do wyszukiwania

Open House Discount Agreements for Icatibant

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Icatibant, ATC B06AC02

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

30 / 100

Czynniki ryzyka

No estimated value or minimum purchase commitment; revenue uncertainty. Buyer may replace open-house with exclusive con...

Strict proof of marketability required; incomplete documentation may delay or prevent participation.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for Icatibant (ATC B06AC02) medicinal products.
  • Contracts valid from June 2025 to May 2027 with rolling monthly entry.
Pokaż pełne podsumowanie

This is an Open House (non-exclusive) discount agreement procedure for the active ingredient Icatibant (ATC B06AC02) organized by AOK Rheinland-Pfalz/Saarland. It is not a public procurement under EU Directive 2014/24 but published for transparency. All pharmaceutical companies can join under uniform terms from June 2025 to May 2027, with monthly entry possible. Estimated value is not provided. Only one lot exists. No procurement documents were analyzed, only the notice itself.

Ryzyka

No estimated value or minimum purchase commitment; revenue uncertainty. Buyer may replace open-house with exclusive con...

Strict proof of marketability required; incomplete documentation may delay or prevent participation.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer) with authorized and marketable medicines in Germany.
  • Medicines must be listed in Lauer-Taxe as marketable or provide proof via AMIce database extracts.
  • Children's medicines (according to BfArM list) are excluded.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria specified; open-house model with uniform terms for all participants.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Agreements for Icatibant

Non-exclusive discount agreements for pharmaceutical products containing Icatibant (ATC B06AC02). Contracts last maximum 24 months, ending no later than 31.05.2027. Entry possible on the first of each month. The buyer may replace open-house contracts with exclusive contracts from competitive procedures. Children's medicines according to BfArM list are excluded.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria specified; open-house model with uniform terms for all participants.

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
235827-2025

Dokumenty (1)

Podobne przetargi